Phytochemical and Therapeutic Profile of <i>Cuscuta chinensis</i> in Classical and Contemporary Formulations

Background: Cuscuta chinensis Lam. is a common parasitic herb used in several Asian nations, such as China, India, and Pakistan. It is a widely consumed Traditional Chinese Medicine herb popularly known by different names, including Tu-si-zi. Historically, it has been applied in the treatment of age-associated diseases, liver and kidney dysfunctions, as well as reproductive problems. Studies show that the plant contains flavonoids, lignans, alkaloids, phenolic acids, polysaccharides, and volatile compounds. Aim: The present review is designed to summarise the pharmacological and biological effects of C. chinensis and its potential clinical utility as an herbal medicine with special emphasis on its formulation approaches. Methods: A literature search has been performed using scientific databases including PubMed. Experimental and review articles discussing phytochemistry, pharmacology, and newer formulations involving C. chinensis were considered for analysis. Special attention has been focused on those that evaluate the biological activity of various extracts as well as new formulations. Results: Experimental investigations have proved the plant’s antioxidant, anti-inflammatory, anti-diabetic, hepatoprotective, renoprotective, neuroprotective, fertility-improving, and anti-ageing properties. Most of the pharmacological activities of C. chinensis are attributed to the ability of the extracts to inhibit oxidative stress markers and reduce inflammation by modulating Nrf2/HO-1 and NF-κB signalling. However, limited by poor aqueous solubility and low oral bioavailability. Recent advancements, including nanoparticle and nanoemulsion-based formulations, have shown improved stability, enhanced bioavailability, and increased therapeutic efficacy at lower doses. Conclusion: C. chinensis holds significant promise as a multifunctional therapeutic agent. Integration of advanced formulation approaches can overcome its pharmacokinetic limitations, supporting i

View article page

Download PDF